Delivery Order SPE2DB20D3303-SPE2DB25FA1MR
- Not listed
- The Defense Logistics Agency awarded a $7,444.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar insulin (100 units/mL, 3mL formulation) with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor, reflecting DLA's ongoing procurement of critical medical supplies for military and federal healthcare systems. The delivery order is issued under...
- The Defense Logistics Agency awarded a $1,301.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin, with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a direct delivery of pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.00 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin, with an ultimate completion date of July 29, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency awarded a $2,119.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin medication, with a completion date of August 1, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively made with no set-aside designation, and performance will...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin, with a ceiling value of $3,456.73. This competitively awarded, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. No set-aside designation was used for...
- The Defense Logistics Agency awarded a delivery order valued at $2,851.90 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin, a diabetes medication, with performance in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract with a completion date of July 24, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- This delivery order, awarded July 25, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 1 million units of Lantus SoloStar 100 Unit/ML 3ML insulin at a ceiling value of $1,429.34. The order, which is non-set-aside and competitively awarded, is scheduled for completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $1,317.48 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award falls under the company's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,917.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin, with an ultimate completion date of July 29, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1MRDelivery Order
The Defense Logistics Agency awarded a $2,144.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin, with an ultimate completion date of July 21, 2025. This non-set-aside award was made competitively on July 18, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its DLA prime contract, which enables the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for diabetes medication insulin supports DLA's medical supply chain operations, reflecting the company's established capability to fulfill federal medical procurement requirements. The contract is structured as part of DLA's pharmaceutical sourcing strategy, which includes plans for multiple regional prime vendor contracts to ensure robust supply chain resilience across the Department of Defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/18/25 |